Skip to main content
. 2020 Feb 28;8:123. doi: 10.3389/fcell.2020.00123

FIGURE 4.

FIGURE 4

Therapeutic potentials by targeting TGF-β signaling. Anti-TGF-β treatment by: (a) targeting upstream signaling; (b) rebalancing Smad3/Smad7 signaling; and (c) targeting Smad3-dependent miRNAs/lncRNAs.